Cancer Vaccine Industry, October 2014 Market Reports from Top Publishers

You might be interested in: Cancer, Therapeutics, Medical Equipment, more »


 
1-10 of about 100 reports for Cancer Vaccine

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Designed to train the immune system to recognize and attack cancer cells and dpx-survivac is a clinical-stage cancer vaccine. Imv's depovax platfrom is a patented vaccine delivery formulation that provides ...

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Medical's imenvax device delivers immune catalysts which activates the patient's immune cell. The company's areas of operations include immuno-therapeutic cancer vaccine for canines, veterinary clinics ...

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

Omnimmune Holdings, Inc. (Symbol:OMMH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... And a multivalent cancer vaccine targeting two epitopes of her-2, vald tumor associated antigens. The company principally focuses on the development of personalized cancer treatment with the selection ...

Key Pharma News 06 OCTOBER 2014

Key Pharma News 06 OCTOBER 2014

  • $ 1 415
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

... To secure its reign over hiv-1 marketindustry trend analysis - cancer vaccine gains first uk promising innovative medicine designationindustry brief - merck presents first phase iii data in japanese ...

Cancer Drug News 29 SEPTEMBER 2014

Cancer Drug News 29 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

... Us licensing deal for mm-398industry trend analysis - cancer vaccine gains first uk promising innovative medicine designationindustry brief - fda grants odd to mabvax' neuroblastoma vaccine ...

Cancer Drug News 15 SEPTEMBER 2014

Cancer Drug News 15 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • September 2014
  • by Espicom Business Intelligence

... Industry brief - sellas/msk sign global licensing deal for wt1 cancer vaccineindustry brief - tracon initiates trc105 phase ii trial in stsindustry trend analysis - tesaro's rolapitant on course to compete ...

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

... vaccines as anti-cancer therapiesfigure 5.5: T-cell based adoptive immunotherapyfigure 5.6: Availability of car-based adoptive immunotherapies ...

Bio-Bridge Science, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bio-Bridge Science, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Serum, which is a major production material in producing vaccines. The company owns the license of papillomavirus pseudovirus technology (original vaccine technology) for the hiv vaccine and colon cancer ...

Affitech AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Affitech AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Asset transactions 32expres2ion biotech acquires ip rights related to recombinant protein production technology from affitech 32affitech completes sale of its remaining rights of cancer vaccine to gemvax 33 ...

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Altor BioScience Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... And treatment of cancer and viral infections for the research and design of anti-viral and anti cancer vaccines. Altor is headquartered in miramar, florida, the us.Altor bioscience corporation ...

About 400 reports for Cancer Vaccine

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Europe

  • Background Paper 6 5 Cancer and Cancer Therapeutics
  • April 2013
    62 pages
  • Cancer  

  • Europe  

    World  

    United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.